LIPOCINE INC. Share-based Payment Arrangement, Expense
LIPOCINE INC. (LPCN) reported Share-based Payment Arrangement, Expense of $242.50 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-03-10
- LIPOCINE INC. share-based payment arrangement, expense for the quarter ending 2021-12-31 was $154.63K, a 34.08% decline year-over-year.
- LIPOCINE INC. share-based payment arrangement, expense for the quarter ending 2021-09-30 was $155.00K, a 55.92% decline year-over-year.
- LIPOCINE INC. share-based payment arrangement, expense for the quarter ending 2021-06-30 was $146.75K, a 68.45% decline year-over-year.
- LIPOCINE INC. share-based payment arrangement, expense for the quarter ending 2021-03-31 was $147.57K, a 54.16% decline year-over-year.
- LIPOCINE INC. share-based payment arrangement, expense for fiscal 2025 was $242.50K, a 40.64% decline from fiscal 2024.
- LIPOCINE INC. share-based payment arrangement, expense for fiscal 2024 was $408.55K, a 37.57% decline from fiscal 2023.
- LIPOCINE INC. share-based payment arrangement, expense for fiscal 2023 was $654.44K, a 2.88% increase from fiscal 2022.
- LIPOCINE INC. share-based payment arrangement, expense for fiscal 2022 was $636.14K, a 5.33% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $242.50K 10-K · filed 2026-03-10 | ||||
| 2024-12-31 | $408.55K 10-K · filed 2026-03-10 | ||||
| 2023-12-31 | $654.44K 10-K · filed 2025-03-13 | ||||
| 2022-12-31 | $636.14K 10-K · filed 2024-03-07 | ||||
| 2021-12-31 | $154.63K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $309.63K derived: sum of 2 quarters · filed 2023-03-10 | $456.38K derived: sum of 3 quarters · filed 2023-03-10 | $603.95K 10-K · filed 2023-03-10 | |
| 2021-09-30 | $155.00K 10-Q · filed 2021-11-10 | $301.75K derived: sum of 2 quarters · filed 2021-11-10 | $449.31K 10-Q · filed 2021-11-10 | $683.90K derived: sum of 4 quarters · filed 2022-03-09 | |
| 2021-06-30 | $146.75K 10-Q · filed 2021-08-05 | $294.31K 10-Q · filed 2021-08-05 | $528.90K derived: sum of 3 quarters · filed 2022-03-09 | $880.52K derived: sum of 4 quarters · filed 2022-03-09 | |
| 2021-03-31 | $147.57K 10-Q · filed 2021-05-06 | $382.15K derived: sum of 2 quarters · filed 2022-03-09 | $733.78K derived: sum of 3 quarters · filed 2022-03-09 | $1.20M derived: sum of 4 quarters · filed 2022-03-09 | |
| 2020-12-31 | $234.59K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $586.21K derived: sum of 2 quarters · filed 2022-03-09 | $1.05M derived: sum of 3 quarters · filed 2022-03-09 | $1.37M 10-K · filed 2022-03-09 | |
| 2020-09-30 | $351.62K 10-Q · filed 2021-11-10 | $816.68K derived: sum of 2 quarters · filed 2021-11-10 | $1.14M 10-Q · filed 2021-11-10 | $1.39M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $465.06K 10-Q · filed 2021-08-05 | $786.97K 10-Q · filed 2021-08-05 | $1.04M derived: sum of 3 quarters · filed 2021-08-05 | $1.10M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | $321.91K 10-Q · filed 2021-05-06 | $576.36K derived: sum of 2 quarters · filed 2021-05-06 | $634.47K derived: sum of 3 quarters · filed 2021-05-06 | $1.08M derived: sum of 4 quarters · filed 2021-05-06 | |
| 2019-12-31 | $254.44K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $312.56K derived: sum of 2 quarters · filed 2021-03-11 | $758.91K derived: sum of 3 quarters · filed 2021-03-11 | $1.04M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $58.11K 10-Q · filed 2020-11-10 | $504.46K derived: sum of 2 quarters · filed 2020-11-10 | $781.39K 10-Q · filed 2020-11-10 | $1.11M derived: sum of 4 quarters · filed 2020-11-10 | |
| 2019-06-30 | $446.35K 10-Q · filed 2020-08-06 | $723.28K 10-Q · filed 2020-08-06 | $1.06M derived: sum of 3 quarters · filed 2020-08-06 | $1.30M derived: sum of 4 quarters · filed 2020-08-06 | |
| 2019-03-31 | $276.93K 10-Q · filed 2020-05-07 | $609.68K derived: sum of 2 quarters · filed 2020-05-07 | $853.21K derived: sum of 3 quarters · filed 2020-05-07 | $1.31M derived: sum of 4 quarters · filed 2020-05-07 | |
| 2018-12-31 | $332.75K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $576.29K derived: sum of 2 quarters · filed 2020-03-13 | $1.03M derived: sum of 3 quarters · filed 2020-03-13 | $1.46M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $243.54K 10-Q · filed 2019-11-12 | $697.69K derived: sum of 2 quarters · filed 2019-11-12 | $1.12M 10-Q · filed 2019-11-12 | $1.62M derived: sum of 4 quarters · filed 2019-11-12 | |
| 2018-06-30 | $454.15K 10-Q · filed 2019-08-07 | $881.43K 10-Q · filed 2019-08-07 | $1.38M derived: sum of 3 quarters · filed 2019-08-07 | $2.32M derived: sum of 4 quarters · filed 2019-08-07 | |
| 2018-03-31 | $427.28K 10-Q · filed 2019-05-08 | $925.71K derived: sum of 2 quarters · filed 2019-05-08 | $1.86M derived: sum of 3 quarters · filed 2019-05-08 | $2.51M derived: sum of 4 quarters · filed 2019-05-08 | |
| 2017-12-31 | $498.43K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $1.44M derived: sum of 2 quarters · filed 2019-03-06 | $2.08M derived: sum of 3 quarters · filed 2019-03-06 | $2.72M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $939.28K 10-Q · filed 2018-11-07 | $1.59M derived: sum of 2 quarters · filed 2018-11-07 | $2.22M 10-Q · filed 2018-11-07 | $2.66M derived: sum of 4 quarters · filed 2019-03-06 | |
| 2017-06-30 | $646.14K 10-Q · filed 2018-08-07 | $1.28M 10-Q · filed 2018-08-07 | $1.72M derived: sum of 3 quarters · filed 2019-03-06 | $2.18M derived: sum of 4 quarters · filed 2019-03-06 | |
| 2017-03-31 | $632.29K 10-Q · filed 2018-05-07 | $1.07M derived: sum of 2 quarters · filed 2019-03-06 | $1.53M derived: sum of 3 quarters · filed 2019-03-06 | $2.27M derived: sum of 4 quarters · filed 2019-03-06 | |
| 2016-12-31 | $438.36K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $898.35K derived: sum of 2 quarters · filed 2019-03-06 | $1.64M derived: sum of 3 quarters · filed 2019-03-06 | $2.37M 10-K · filed 2019-03-06 | |
| 2016-09-30 | $459.99K 10-Q · filed 2017-11-08 | $1.20M derived: sum of 2 quarters · filed 2017-11-08 | $1.93M 10-Q · filed 2017-11-08 | $2.34M derived: sum of 4 quarters · filed 2018-03-12 | |
| 2016-06-30 | $740.77K 10-Q · filed 2017-08-07 | $1.47M 10-Q · filed 2017-08-07 | $1.88M derived: sum of 3 quarters · filed 2018-03-12 | $2.24M derived: sum of 4 quarters · filed 2018-03-12 | |
| 2016-03-31 | $733.50K 10-Q · filed 2017-05-08 | $1.14M derived: sum of 2 quarters · filed 2018-03-12 | $1.50M derived: sum of 3 quarters · filed 2018-03-12 | $1.71M derived: sum of 4 quarters · filed 2018-03-12 | |
| 2015-12-31 | $408.58K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $762.64K derived: sum of 2 quarters · filed 2018-03-12 | $971.65K derived: sum of 3 quarters · filed 2018-03-12 | $1.15M 10-K · filed 2018-03-12 | |
| 2015-09-30 | $354.06K 10-Q · filed 2016-11-08 | $563.07K derived: sum of 2 quarters · filed 2016-11-08 | $741.84K 10-Q · filed 2016-11-08 | $1.18M derived: sum of 4 quarters · filed 2017-03-06 | |
| 2015-06-30 | $209.01K 10-Q · filed 2016-08-09 | $208.74K 10-Q · filed 2015-08-11 | $387.78K 10-Q · filed 2016-08-09 | $826.99K derived: sum of 3 quarters · filed 2017-03-06 | $1.07M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | $179.04K 10-Q · filed 2016-05-09 | $617.98K derived: sum of 2 quarters · filed 2017-03-06 | $857.75K derived: sum of 3 quarters · filed 2017-03-06 | $1.03M derived: sum of 4 quarters · filed 2017-03-06 | |
| 2014-12-31 | $438.94K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $678.71K derived: sum of 2 quarters · filed 2017-03-06 | $847.45K derived: sum of 3 quarters · filed 2017-03-06 | $1.89M 10-K · filed 2017-03-06 | |
| 2014-09-30 | $239.77K 10-Q · filed 2015-11-12 | $408.51K derived: sum of 2 quarters · filed 2015-11-12 | $1.45M 10-Q · filed 2015-11-12 | $1.67M derived: sum of 4 quarters · filed 2015-11-12 | |
| 2014-06-30 | $168.74K 10-Q · filed 2015-08-11 | $1.21M 10-Q · filed 2015-08-11 | $1.43M derived: sum of 3 quarters · filed 2015-08-11 | $1.59M derived: sum of 4 quarters · filed 2015-08-11 | |
| 2014-03-31 | $1.05M 10-Q · filed 2015-05-07 | $1.27M derived: sum of 2 quarters · filed 2015-05-07 | $1.43M derived: sum of 3 quarters · filed 2015-05-07 | $1.54M derived: sum of 4 quarters · filed 2015-05-07 | |
| 2013-12-31 | $220.38K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $380.67K derived: sum of 2 quarters · filed 2015-03-11 | $498.85K derived: sum of 3 quarters · filed 2015-03-11 | $979.15K 10-K · filed 2015-03-11 | |
| 2013-09-30 | $160.28K 10-Q · filed 2014-11-10 | $278.46K derived: sum of 2 quarters · filed 2014-11-10 | $758.77K 10-Q · filed 2014-11-10 | $769.41K derived: sum of 4 quarters · filed 2014-11-10 | |
| 2013-06-30 | $118.18K 10-Q · filed 2014-08-13 | $598.49K 10-Q · filed 2014-08-13 | $609.13K derived: sum of 3 quarters · filed 2014-08-13 | $646.03K derived: sum of 4 quarters · filed 2014-08-13 | |
| 2013-03-31 | $480.31K 10-Q · filed 2014-05-13 | $490.95K derived: sum of 2 quarters · filed 2014-05-13 | $527.85K derived: sum of 3 quarters · filed 2014-05-13 | ||
| 2012-12-31 | $10.64K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $47.54K derived: sum of 2 quarters · filed 2014-03-31 | $127.49K 10-K · filed 2014-03-31 | ||
| 2012-09-30 | $36.90K 10-Q · filed 2013-11-13 | $116.84K 10-Q · filed 2013-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |